Relevant bibliographies by topics / Haematology

Academic literature on the topic 'Haematology'

Author: Grafiati
Published: 4 June 2021
Last updated: 31 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Haematology.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Haematology"

1

Baker, Ross I., Alison M. Street, and Kerry M. Taylor. "Haematology." Medical Journal of Australia 176, no. 1 (January 2002): 19. http://dx.doi.org/10.5694/j.1326-5377.2002.tb04252.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Isbister, James P. "Haematology." Medical Journal of Australia 150, no. 9 (May 1989): 528. http://dx.doi.org/10.5694/j.1326-5377.1989.tb136628.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dintenfass, Leopold. "Haematology." Medical Journal of Australia 150, no. 9 (May 1989): 528. http://dx.doi.org/10.5694/j.1326-5377.1989.tb136629.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hall, G. M. "Haematology." Current Opinion in Anaesthesiology 3, no. 3 (June 1990): 449–51. http://dx.doi.org/10.1097/00001503-199006000-00027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Reid, M. M. "Haematology." Journal of Clinical Pathology 53, no. 1 (January 1, 2000): 4. http://dx.doi.org/10.1136/jcp.53.1.4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hounsell, John, and James P. Isbister. "Haematology." Medical Journal of Australia 160, no. 1 (January 1994): 38–40. http://dx.doi.org/10.5694/j.1326-5377.1994.tb138201.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Morris, Joanna S., and John K. Dunn. "Haematology." In Practice 14, no. 2 (March 1992): 67–72. http://dx.doi.org/10.1136/inpract.14.2.67.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hawkey, Christine M. "Haematology." Transactions of the Zoological Society of London 33, no. 2 (July 8, 2010): 99–101. http://dx.doi.org/10.1111/j.1096-3642.1976.tb00039.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Armstrong, B. "Haematology." ISBT Science Series 3, no. 2 (June 2008): 1–9. http://dx.doi.org/10.1111/j.1751-2824.2008.00183.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bradlow, Basil A. "Haematology." Reviews in Clinical Gerontology 5, no. 1 (February 1995): 27–32. http://dx.doi.org/10.1017/s0959259800003956.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Haematology"

1

Gray, Atherton. "Immunoliposomes in haematology." Thesis, University of Edinburgh, 1992. http://hdl.handle.net/1842/26559.

Full text
Abstract:
The aim of this thesis was to use antibody-directed liposomes to enhance the targeting of 1. fluorescent compounds for the detection of cell surface antigens and 2. cytotoxic compounds for delivery to specific cell populations. This involved the selection and production of a suitable species of liposome-protein conjugate from among those described in the literature. The choice was a small unilamellar liposome conjugated either to antibody or protein A via a covalent linkage mediated by the heterobifunctional reagent SPDP. Anti-immunoglobulin antibody was a more universal ligand than either specific antibody or protein A. The conjugate was made fluorescent by the encapsulation of carboxyfluorescein (CF) in the liposome and the maximally fluorescent concentration was determined at 20 mM CF. The probe was stable on storage over many months and had low non-specific staining characteristics. Applied to lymphocytes it gave a signal enhancement in order of magnitude greater than the conventional fluorescent-antibody method as measured by flow cytometry. This permitted the demonstration of the interleukin-2 receptor on resting polyclonal T-lymphocytes hitherto undetectable by conventional fluorescence. This set the threshold of detectability at approximately 1000 antigen copies per cell.
APA, Harvard, Vancouver, ISO, and other styles
2

Mainwaring, Gary. "Aspects of fish haematology." Thesis, Swansea University, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.627994.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Swart, Luhan. "HIV-associated Hodgkin lymphoma at Groote Schuur Hospital, Western Cape, South Africa." Master's thesis, University of Cape Town, 2017. http://hdl.handle.net/11427/27282.

Full text
Abstract:
Background: Human immunodeficiency virus (HIV) is associated with an increased risk of developing Hodgkin lymphoma (HL). South Africa (SA) has the highest HIV prevalence rate in the world. There is currently no 5-year overall survival (OS) outcome based data for HIV-associated HL from SA. Methods: A bone marrow database was compiled of all bone marrow biopsies (BMB) reported at National Health Laboratory Service (NHLS) Groote Schuur Hospital (GSH) between January 2005 and December 2012. Patients who had a BMB performed for staging of HL or where HL was diagnosed on the BMB were included for further analysis. Clinical and laboratory data was extracted from medical and laboratory records. Primary outcome measures included histological subtype, bone marrow infiltration (BMI) by HL, CD4 count, HIV-viral load (HIV-VL), tuberculosis (TB) data, treatment with chemotherapy and 5-year overall survival (OS). Results: The database included 6569 BMB and 219 patients of these had HL and were included for analysis. The median age at presentation (32 years) was similar in the HIV+ and HIV-populations. While males predominated in the HIV-group, females predominated in the HIV+ group (male:female ratio of 1.5:1 vs 0.7:1, respectively). The majority of patients (71%) were HIV negative (HIV-) and 29% were HIV positive (HIV+). The diagnosis of HL was made on BMB in 17% of cases. BMI was seen in 37%(82/219) overall, and was found in more HIV+ patients (61%; 39/64) than HIV-patients (28%; 43/155; p= 0.03). The histological subtype varied according to HIV status with nodular sclerosis classical Hodgkin lymphoma (NSCHL) being most frequent in the HIV-group and classical Hodgkin lymphoma (CHL)-unclassifiable the most frequent in the HIV+ group. HIV+ patients had a median CD4 count of 149 x106/L and 39% were anti-retroviral therapy (cART) naive at HL diagnosis. HIV+ patients had received anti-TB therapy more frequently than HIV-patients (72% vs 17%; p= 0.007). More HIV+ patients did not receive chemotherapy than HIV-patients (31% vs 3%; p= 0.001). The 5-year OS was 56%. HIV+ patients with BMI had a 5-year OS of 18%. BMI, HIV status, low CD4 count, histological subtype and TB therapy had a statistical significant impact on 5-year OS (p< 0.01). Conclusion: BMB provided the diagnosis of HL in 17% of cases, confirming its diagnostic utility in our setting. BMI by HL was more common in HIV+ patients and was associated with significantly worse survival. Our cohort showed similar survival outcomes to other countries in Africa, Asia and Central America with comparable socio-economic constraints to SA.
APA, Harvard, Vancouver, ISO, and other styles
4

Antel, Katherine. "Splenectomy for immune thrombocytopenia : our 11-year experience." Master's thesis, University of Cape Town, 2015. http://hdl.handle.net/11427/14134.

Full text
Abstract:
Splenectomy has been practiced for the treatment of ITP for the past few decades. Currently it is utilised when a patient is either dependent or resistant to steroid treatment and the platelet count remains less than 30×109/L. Recently new agents have been added to the armamentarium used to treat ITP, including immune-suppressants such as rituximab and the new thrombopoetin-receptor agonists. This has brought into question the role of surgery for the treatment of ITP, and the need to compare the response and complication rates of splenectomy to these newer agents. Historic studies done on splenectomy for the treatment of ITP have been performed in the setting of low HIV prevalence. There is a relative paucity of data on the response rate in HIV-associated thrombocytopenia to splenectomy and the durability of response to splenectomy is unclear in this patient population. We retrospectively analysed 73 consecutive patients who underwent splenectomy for ITP from 2001 to 2011. The primary objective was to determine the rate of complete response, this was defined as a platelet count greater than 100×109/L at one year post splenectomy. Results were compared between HIV positive and HIV negative patients. The secondary objectives were: to evaluate the intra-operative and post†operative complications and mortality in the HIV positive and HIV negative groups, and to investigate for associations between co-morbidities, pre-operative treatment and response to splenectomy.
APA, Harvard, Vancouver, ISO, and other styles
5

Van, Schalkwyk Willem Adendorff. "The diagnostic utility of bone marrow biopsies performed for the investigation of fever and/or cytopenias in HIV-infected adults at Groote Schuur Hospital." Master's thesis, University of Cape Town, 2009. http://hdl.handle.net/11427/2834.

Full text
Abstract:
This is a retrospective review of the results of consecutive bone marrow biopsies performed at our institution over a three year period on HIV positive patients for the investigation of fever and cytopenias. Clinical data, haematological parameters, morphology of bone marrow biopsy, Ziehl-Neelsen staining and microbiological culture results were analyzed. The aim of the study was to determine the diagnostic yield of this investigation.
APA, Harvard, Vancouver, ISO, and other styles
6

Makgoka, Seretloane Japhtaline. "Effects of bFGF (Basic Fibroblast growth factor) on the Haematopoietic Sequelae that follow transplantation." Master's thesis, University of Cape Town, 2000. http://hdl.handle.net/11427/25551.

Full text
Abstract:
Recovery following bone marrow transplantation is associated with the reduction in the clonogenic potential of stroma-adherent CD34⁺ progenitors. The bone marrow stroma is also affected, resulting in poor support for the growth of stroma-adherent multipotent progenitors that form blastic colonies (CFU-bl). To determine the possible mechanisms of marrow damage in patients treated with peripheral blood stem cells (PBSCs) and bone marrow transplantation (BMT), we studied the effects of bFGF, a cytokine known to stimulate the survival and proliferation of fibroblasts, on the propagation of clonogenic progenitors and the marrow stroma. METHODS: In order to obtain the optimal bFGF concentrations to be used on patients' haematopoietic progenitors and bone marrow rnicroenvironment, haematologically normal individuals were studied in dose response studies. Control mononuclear cells from the Ficoll-Histopaque interface layer were divided into two aliquots: one to establish a stromal layer and to culture fibroblastic progenitors (CFU-Fs) in the presence of 0, 2 and 20 ng/ml bFGF with and without 20 ng/ml heparan sulphate (HS). The second aliquot was for the selection of the progenitor population. Stroma was quantitated by placing culture dishes on a grid containing 1mm squares and scoring the number of squares occupied by stromal layers as the percentage area covered. After 3 weeks of culture, a single cell suspension was prepared by incubation of stroma with 5% trypsin solution, and number of cells in the dishes enumerated with a particle counter. CFU-Fs were terminated on the 9th day of culture, stained with May-Grilnwald-Giemsa and scored using an inverted microscope. From the second aliquot, CD34⁺ cells were incubated with paramagnetic beads and target cells isolated with a magnet. Selected l x l 04/ml cells were cultured on prefom1ed controls' stroma that has been treated with 0, 2 and 20 ng/ml bFGF. Stroma-adhered cells were covered with 0.3% agar and cultured for 6 days. Aggregates of more than 20 cells were counted as CFU-bl. RESULTS: In normal individuals, the median surface area of the petri dish covered by stroma at 3 weeks of culture was 55% (range 30-65) and was significantly improved upon the addition of 2 ng/ml (median 70%; range 50-95 ; p= <0.05) and 20 ng/ml bFGF (median 80%; range 65-99; p= 0.004). Stromal cell numbers were 0.61 x 10⁶/2ml (range 0. 15-1.66), and they increased significantly with the addition of 2 and 20 ng/ml bFGF (p=0.03). The median colony forming unit-blasts (CFU-bl) scores were 121.8 x 10⁴/ml (range 43-271), and they expanded significantly with the addition of 20 ng/ml bFGF with and without heparan sulphate (p=0.03 and 0.01). It was then concluded that the 2 and 20 ng/ml bFGF with heparan sulphate be used on patients' cells in vitro. The median surface area covered by stromal layers in patients' samples at 3 weeks was 40% (range 0-55 vs. normal 50%), and it was in1proved significantly upon the addition of bFGF (median 78 vs. 50%; p= 0.001). Supplementation of stromal layers with bFGF accounted for a significant increase in patients stromal cell numbers (2.11 vs. normal 0.61 x 106/2ml; p< 0.05). Patients' CD34⁺ cells panned on normal stromal layers resulted in significantly fewer CFU-bl (median 40 vs. normal 90 x 10⁴/ml CFU-bl; p=0.009), but CFU-bl numbers were corrected following the addition of bFGF, matching the scores achieved by normal individuals (85 vs. normal 90 x l 04/ml). Normal CD34⁺ cells proliferated poorly on patients' stromal layers in the absence of bFGF (3 9 vs. normal 90 x 10⁴/ml), but colony numbers increased significantly upon addition of bFGF (91 vs. normal 90 x 10⁴/ml CFU-bl). Thirteen patients receiving peripheral blood stem cells (PBSCs) and nine patients undergoing bone marrow transplantation (BMT) were compared. These two stem cell sources were then compared to the normal population. Stromal layers in patients receiving PBSC grafts covered a greater surface area than the area covered in patients undergoing BMT (median 65 vs. 30%). They also had higher blastic colony than scores from BMT recipients (47 vs. 12 x 10⁴/ml CFU-bl; p= 0.2). Results can be summarized that bone marrow stroma from patients receiving mobilized progenitor cells proliferates better than those receiving bone marrow grafts. It can be concluded that poor stromal layer and CD34⁺ cell proliferation following peripheral blood stem cell transplantation can be corrected by addition of basic Fibroblastic Growth Factor.
APA, Harvard, Vancouver, ISO, and other styles
7

Seth, Yunus S. "Review and re-appraisal of patients treated with splenectomy for immune thrombocytopenic purpura at five years and beyond." Master's thesis, University of Cape Town, 2002. http://hdl.handle.net/11427/2833.

Full text
Abstract:
Includes bibliographical references.
The risk of pneumococcal infection post splenectomy is life long so all patients undergoing splenectomy are given polyvalent (23-valent) unconjugated pneumococcal polysaccharide vaccine, preoperatively. The aim of this study was 1. to measure the success of splenectomy at a tertiary institution at 5 years and beyond. 2. To review the incidence of complications peri-operatively and long term. 3. Review the need for possible re-vaccination (as recommended in American and British guidelines and 4. perform a re-appraisal of patients found to be refractory to treatment.
APA, Harvard, Vancouver, ISO, and other styles
8

Goolam, Hoosen Taahira. "Identification and characterisation of micrornas involved in the pathogenesis of HIV–associated non-Hodgkin's lymphoma." Master's thesis, University of Cape Town, 2017. http://hdl.handle.net/11427/24883.

Full text
Abstract:
Background: Since its discovery about three decades ago, the Human Immunodeficiency Virus (HIV) has claimed over millions of lives globally. Although our understanding of the mode of transmission and action of this causative agent for the Acquired Immune Deficiency Syndrome (AIDS) has increased through research, and treatment regimens developed and improved, in certain parts of the world the pandemic continues to expand. Sub-Saharan Africa, which is the epicentre of this global health concern, accounts for approximately 66% of the total number of individuals affected, with South Africa enduring the heaviest burden. South Africa has the world's largest antiretroviral therapy (ART) programme and as such, HIV infected people are living longer, and consequently the incidence of HIV co-morbidities has increased dramatically. HIV/AIDS defining cancers are such co-morbidities with Non- Hodgkin's lymphomas (NHL) being the second most common HIV-associated cancer. Diffuse Large B-cell lymphoma (DLBCL) and Burkitt's lymphoma (BL) are the main subtypes and both present aggressively in HIV positive patients with rapid progression. The use of highly active antiretroviral therapy (HAART) has decreased the incidence of DLBCL in HIV positive patients, however the prevalence of these cancers still remain high in some settings. It has been suggested that the pathogenesis of these cancers in HIV infected individuals is complex and different to that in HIV uninfected individuals, with the possibility that the virus may have an oncogenic role. This has already been demonstrated in the case of the HIV/AIDSdefining cancer Kaposi Sarcoma. However, the same has not been unequivocally demonstrated in HIV-associated NHL. In light of this, the mechanisms through which viruses and viral components promote cellular transformation is an area of active research. One of these mechanisms manipulated by viruses is through the dysregulation of cellular microRNAs (miRNAs) which are small non-coding RNA molecules that are key regulators of gene expression. While they are essential for normal cellular functioning, their expression has been found to be deregulated in diseases including cancer. Several studies have described specific miRNA signatures for NHLs including for DLBCL and BL but none have been described for the HIV-association of these cancers. Aim: The aim of this project was to identify and characterise miRNAs involved in the pathogenesis of HIV-associated NHLs. This thesis reports on the changes in expression of miRNAs in B-cells exposed to an attenuated form (structurally intact but non-infectious) of HIV. Methods: We designed a custom miRNA microarray to identify deregulated miRNAs in the BL cell line Ramos that were exposed to HIV compared to microvesicle treated cells. It was initially planned to use both normal B-cells (L1439A) and BL cells for analysis but Ramos was selected due to technical reasons for this step. Thereafter we validated selected miRNAs by quantitative real-time PCR (qPCR) using single-tube TaqMan® Assays which was predominantly performed in the lymphoblastoid cell line L1439A, which is derived from a healthy donor. We then focused on further characterising the role of one miRNA in the development of HIV-associated NHL by using prediction programmes to predict its putative gene targets and then confirmed its target by using qPCR and western blot analyses. Results: Extensive and comprehensive analysis of the array data led to the identification of a large number of miRNAs which were differentially expressed, with 32 being selected for further studies. These 32 miRNAs include 16 upregulated and 16 downregulated miRNAs, and were selected because they displayed changes in expression by two or more folds. Thereafter, four miRNAs, namely miR-363-3p, miR-222-3p, miR-200c-3p and miR-575, were chosen for validation based on their reported involvement in cancer for validation. The results of two miRNAs (miR-575 (upregulated) (p<0.05) and miR-200c-3p (downregulated) (p<0.05)) were found to be consistent with the results obtained from the miRNA microarray whilst the other two were opposite to that result (both downregulated) (p<0.05). Using online tools as well as the published literature, several potential target genes of miR-575 were identified, namely DENND5A, CDK1, CSTA and ATAD5. One particular target, the BH3- like motif containing inducer of cell death (BLID), which is involved in apoptosis, has previously been confirmed as a gene target in non small cell lung cancer. Using qPCR, we found that BLID messenger RNA (mRNA) was downregulated in normal B-cells when exposed to HIV-1 AT-2. Unfortunately, the BLID protein could not be detected using western blot analysis despite several attempts at detecting varying concentrations of the protein and using two different positive control cell lines. Conclusion: The reverse correlation, between miR-575 and BLID mRNA expression in the same cell line and under the same treatment conditions, supports the notion that the downregulation of miR-575 may be physiologically relevant. However, this could not be further verified as the BLID protein could not be detected in the L1439A cells, even in the microvesicle treated control cells. Future studies should look at further characterisation of miR- 575 in the pathogenesis of HIV-associated NHLs by investigating other predicted gene targets of the miRNA. This will then be followed by loss and gain of function assays to confirm the miRNA:mRNA relationship. Furthermore, functional analyses, such as measure of apoptosis, expression of key regulators of the cell cycle, and other cellular events characteristic of cancer should be carried out to define the role of the miR-575 in the development of HIV-associated lymphoma.
APA, Harvard, Vancouver, ISO, and other styles
9

Wu, Erxi. "Expression and regulation of ADAMs in cells derived from a range of haematological malignancies." Thesis, University of Sheffield, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.312292.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Strouboulis, Ioannis John. "Regulation of the complete human #beta#-globin gene locus in transgenic mice." Thesis, Open University, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.239790.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Haematology"

1

Linch, David C. Haematology. New York: Churchill Livingstone, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Linch, David C. Haematology. Edinburgh: Churchill Livingstone, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

P, Yates A., ed. Haematology. Edinburgh: Churchill Livingstone, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

R, McCann Shaun, ed. Haematology. Oxford: Wiley-Blackwell, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Dr, Knight Gavin, and Moore Gary Dr, eds. Haematology. Oxford: Oxford University Press, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Smith, Graeme. Haematology. Oxford: Clinical Publishing,an imprint of Atlas Medical Publishing Ltd, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Gary, Moore. Haematology. Oxford: Oxford University Press, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Brown, Marvelle, and Tracey J. Cutler. Haematology Nursing. West Sussex, UK: John Wiley & Sons, Ltd., 2012. http://dx.doi.org/10.1002/9781118702949.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hoffbrand, A. Victor, Daniel Catovsky, Edward GD Tuddenham, and Anthony R. Green, eds. Postgraduate Haematology. Oxford, UK: Wiley-Blackwell, 2010. http://dx.doi.org/10.1002/9781444323160.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Hoffbrand, A. Victor, Daniel Catovsky, and Edward G. D. Tuddenham, eds. Postgraduate Haematology. Oxford, UK: Blackwell Publishing Ltd, 2005. http://dx.doi.org/10.1002/9780470987056.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Haematology"

1

Mokbel, K. M. "Haematology." In MCQs in Applied Basic Sciences, 112–15. Dordrecht: Springer Netherlands, 1992. http://dx.doi.org/10.1007/978-94-011-2998-5_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Pollycove, M. "Haematology." In Clinical Nuclear Medicine, 35–37. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4899-3356-0_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Peters, A. M., and S. M. Lewis. "Haematology." In Clinical Nuclear Medicine, 346–82. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4899-3358-4_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

King, Debra, and Susan J. Benbow. "Haematology." In MCQs in Medicine, 97–120. Boston, MA: Springer US, 1994. http://dx.doi.org/10.1007/978-1-4684-6476-4_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bentley, Paul, and Ben Lovell. "Haematology." In Memorizing Medicine, 431–52. Second edition. | Boca Raton, FL : Taylor & Francis Group, [2019] | Only Paul Bentley’s name appears in the previous edition.: CRC Press, 2019. http://dx.doi.org/10.1201/9780429446405-10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hughes, Andy. "Haematology." In Instant Wisdom for GPs, 77–83. Boca Raton : CRC Press/Taylor & Francis Group, [2018] |Includes bibliographical references and index.: CRC Press, 2017. http://dx.doi.org/10.1201/9781315116808-12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kaushal, Rashmi, Rikin Trivedi, and Sanjay Sharma. "Haematology." In Rapid Review of Clinical Medicine for MRCP Part 1, 83–96. London: CRC Press, 2021. http://dx.doi.org/10.1201/9780429158797-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

McGhee, Michael F., Caroline A. Saxelby, and Niall McKay. "Haematology." In A Guide to Laboratory Investigations, 1–32. 7th ed. Boca Raton: CRC Press, 2021. http://dx.doi.org/10.1201/9781003049685-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Imam, Ibrahim. "Haematology." In 700 Essential Neurology Checklists, 402–3. New York: CRC Press, 2021. http://dx.doi.org/10.1201/9781003221258-127.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Khan, Muhammad Azaan, Gizem Ashraf, Hamza Ashraf, Saad Ashraf, Yusuf Hassan, Alisha Rawal, Imaan Ashraf, Qazi Sarem Shahab, and Zehra Hasimoglu. "Haematology." In Medical Analogies for Clinician-Patient Communication, 65–71. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-87293-9_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Haematology"

1

Varese, A., M. Scaldaferri, E. Buffa, E. Ferrarato, MR Chiappetta, and F. Cattel. "CP-105 Clinical trials in haematology." In 22nd EAHP Congress 22–24 March 2017 Cannes, France. British Medical Journal Publishing Group, 2017. http://dx.doi.org/10.1136/ejhpharm-2017-000640.104.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Travers, Alice, and Graeme Donald. "80 What prevents advance care planning in haematology?" In The APM’s Annual Supportive and Palliative Care Conference, In association with the Palliative Care Congress, “Towards evidence based compassionate care”, Bournemouth International Centre, 15–16 March 2018. British Medical Journal Publishing Group, 2018. http://dx.doi.org/10.1136/bmjspcare-2018-aspabstracts.107.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Nightingale, Laura, and Joseph Low. "11 Haematology specialty registrars’ training in palliative care." In The APM’s Annual Supportive and Palliative Care Conference, In association with the Palliative Care Congress, “Towards evidence based compassionate care”, Bournemouth International Centre, 15–16 March 2018. British Medical Journal Publishing Group, 2018. http://dx.doi.org/10.1136/bmjspcare-2018-aspabstracts.38.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Rao, A., J. Chalker, and L. Wilkhu. "D2.2 Advances in molecular diagnostics in paediatric haematology oncology." In Great Ormond Street Hospital Conference. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2017. http://dx.doi.org/10.1136/archdischild-2017-084620.34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Torres, HJ Del Río, A. Manzaneque Gordon, C. Chaguaceda Galisteo, C. Codina Jané, and N. Creus Baró. "DI-093 Off-label drug use in onco-haematology setting." In 22nd EAHP Congress 22–24 March 2017 Cannes, France. British Medical Journal Publishing Group, 2017. http://dx.doi.org/10.1136/ejhpharm-2017-000640.340.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lorenzo, M. Gutiérrez, C. Fernández Cuerva, and B. Mora Rodríguez. "4CPS-102 Analysis of off-label use in onco-haematology." In Abstract Book, 23rd EAHP Congress, 21st–23rd March 2018, Gothenburg, Sweden. British Medical Journal Publishing Group, 2018. http://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.193.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Báez Gutiérrez, N., H. Rodríguez Ramallo, L. Abdel-Kader Martín, S. Flores Moreno, and B. Fernandez Rubio. "6ER-026 Credibility of subgroup claims in haematology clinical trials." In 25th Anniversary EAHP Congress, Hospital Pharmacy 5.0 – the future of patient care, 23–28 March 2021. British Medical Journal Publishing Group, 2021. http://dx.doi.org/10.1136/ejhpharm-2021-eahpconf.350.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Monici, Monica, Giovanni Agati, Piero Mazzinghi, Franco Fusi, Pietro A. Bernabei, Stefano Landini, Pierluigi R. Ferrini, and Riccardo Pratesi. "Image analysis of cell natural fluorescence: diagnostic applications in haematology." In BiOS Europe '96, edited by Nathan I. Croitoru, Martin Frenz, Terence A. King, Riccardo Pratesi, Anna M. Verga Scheggi, Stefan Seeger, and Otto S. Wolfbeis. SPIE, 1996. http://dx.doi.org/10.1117/12.259969.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Awortu Jeremiah, Prof Zaccheaus, Prof Osaro Erhabor, and Prof Musa Abidemi Muhibi. "Book of Proceedings of the First International Congress of the HBTSSN 2020." In 1st INTERNATIONAL CONGRESS. Haematology and Blood Transfusion Scientists Society of Nigeria, 2020. http://dx.doi.org/10.59708/hbtssn-preceedings-2020.

Full text
Abstract:
The Book of proceedings of the first international congress of the Haematology and Blood Transfusion Scientists Society of Nigeria is a compendium of the academic contents of the events that transpired during the congress tagged HBTSSN 2020 with the theme Healthy Blood, Healthy Nation: The haematology Scientists perspective. It is a collection of papers presented from the 17th to 19th of March 2020 at the Hotel Presidential, Port Harcourt, Nigeria. The publication of this congress proceedings is meant to serve the following purposes: Providing a great place for participants to present their research findings, novel approaches or new methodology. Allowing researchers to engage with the research teams and community doing research on the same subject. Staging and spreading the new ideas to the scientific community. The HBTSSN benefits from publishing the proceedings as it creates awareness and adds value to our great society. Attracts more authors to participate in future conferences. It’s a faster way of making your results available to the wider world Citable for academic appointments and promotions This congress proceedings is having a unique ISBN number and is catalogued in the National Library. It comprises of three parts: 1) Keynote and plenary lectures. 2) Abstracts of original articles for oral and poster presentations and 3) Workshop papers on Building a successful research career in Haematology and Blood Transfusion I wish to acknowledge the efforts of the Chairman of Scientific committee, Prof Osaro Erhabor and other distinguished members of the scientific committee for their diligence in reviewing the abstracts submitted to this congress. I also thank the speakers who made their papers available for publication. This is the maiden edition and we hope to improve in the subsequent editions. I sincerely wish that every participant will find this book of proceedings useful. Prof Z. A. Jeremiah President
APA, Harvard, Vancouver, ISO, and other styles
10

Awortu Jeremiah, Prof Zaccheaus, Osaro Erhabor, and Musa Abidemi Muhibi. "Book of Proceedings of the First International Congress of the HBTSSN 2020." In 1st INTERNATIONAL CONGRESS. Haematology and Blood Transfusion Scientists Society of Nigeria, 2020. http://dx.doi.org/10.59708/hbtssn.preceedings.2020.

Full text
Abstract:
The Book of proceedings of the first international congress of the Haematology and Blood Transfusion Scientists Society of Nigeria is a compendium of the academic contents of the events that transpired during the congress tagged HBTSSN 2020 with the theme Healthy Blood, Healthy Nation: The haematology Scientists perspective. It is a collection of papers presented from the 17th to 19th of March 2020 at the Hotel Presidential, Port Harcourt, Nigeria. The publication of this congress proceedings is meant to serve the following purposes: Providing a great place for participants to present their research findings, novel approaches or new methodology. Allowing researchers to engage with the research teams and community doing research on the same subject. Staging and spreading the new ideas to the scientific community. The HBTSSN benefits from publishing the proceedings as it creates awareness and adds value to our great society. Attracts more authors to participate in future conferences. It’s a faster way of making your results available to the wider world Citable for academic appointments and promotions This congress proceedings is having a unique ISBN number and is catalogued in the National Library. It comprises of three parts: 1) Keynote and plenary lectures. 2) Abstracts of original articles for oral and poster presentations and 3) Workshop papers on Building a successful research career in Haematology and Blood Transfusion I wish to acknowledge the efforts of the Chairman of Scientific committee, Prof Osaro Erhabor and other distinguished members of the scientific committee for their diligence in reviewing the abstracts submitted to this congress. I also thank the speakers who made their papers available for publication. This is the maiden edition and we hope to improve in the subsequent editions. I sincerely wish that every participant will find this book of proceedings useful. Prof Z. A. Jeremiah President
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Haematology"

1

Andreev, Nikolay, Evdokia Sotirova, and Simeon Ribagin. Intercriteria Analysis of Data from the Centres for Transfusion Haematology in Bulgaria. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, July 2019. http://dx.doi.org/10.7546/crabs.2019.07.17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Haematology' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography